CSE:KETA - Post Discussion
Post by
XeniaTechie on Jan 04, 2022 3:23pm
2022 will be the year ketamine therapies make the mainstream
Mark my words - 2022 will see Ketamine assisted therapies hit the mainstream. A recent study is reporting a single or multiple dose of ketamine resulted in moderate to large reductions in suicidal thoughts and depression. It’s a staggering improvement that can be observed within hours of the treatment. At only $0.22 this is such a hot time to get in on TripSitter an mHealth company connecting patients with at-home ketamine treatments. https://www.studyfinds.org/ketamine-reduces-depression-suicidal-thoughts-within-hours/
Be the first to comment on this post